Literature DB >> 28029275

Oligodendroglial cell proliferation arising in an ovarian mature cystic teratoma. Clinicopathological, inmunohistochemical, and ultrastructural study of a case that may represent an oligodendroglioma.

Mónica Lizzette Serrano-Arévalo1, Leonardo Saúl Lino-Silva1, Hugo Ricardo Domínguez Malagón1.   

Abstract

Ovarian mature cystic teratoma (OMCT) is an ovarian benign neoplasm with excellent prognosis presenting components of the three germinal layers. However, transformation into a malignant neoplasm is a rare event (so-called somatic transformation). In most of the cases, the malignant component expresses as epidermoid carcinoma, but occasionally central nervous system tumors occur. Some of the previously reported tumors are astrocytoma, glioblastoma, and ependymoma. Somatic transformation of OMCT into an oligodendroglioma is exceptional. We report a 19-year-old female with a left OMCT with an area of oligonedroglial cells proliferation characterized by immunohistochemical studies with positivity for GFAP and S100, with a low Ki67 index (5%). Additionally, electron microscopy revealed oligodendrocytes with parallel bundles of cytoplasmic intermediate filaments, confirming the oligodendroglial nature of the proliferation. The patient was treated only with left oophorectomy, and three and half years after surgery, there is no evidence of disease.

Entities:  

Keywords:  Oligodendroglioma; ovary; teratoma; ultrastructure

Mesh:

Substances:

Year:  2016        PMID: 28029275     DOI: 10.1080/01913123.2016.1261975

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  1 in total

1.  Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Aude Chefdeville; Isabelle Treilleux; Marie-Eve Mayeur; Coline Couillault; Géraldine Picard; Chloé Bost; Karima Mokhtari; Alexandre Vasiljevic; David Meyronet; Véronique Rogemond; Dimitri Psimaras; Bertrand Dubois; Jérôme Honnorat; Virginie Desestret
Journal:  Acta Neuropathol Commun       Date:  2019-03-11       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.